Charles River Laboratories
CRL
NZ$299.42
Share price
-0.30%
Change (1 day)
-25.72%
Change (1 year)
Categories
P/S ratio for Charles River Laboratories (CRL)
P/S ratio as of July 2025 (TTM): 2.18
According to Charles River Laboratories 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.70. At the end of 2025 the company had a P/S ratio of 1.98.
P/S ratio history for Charles River Laboratories from 2001 to 2025
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2025 | 1.98 | -15.86% |
| 2024 | 2.35 | -19.96% |
| 2023 | 2.94 | 5.32% |
| 2022 | 2.79 | -48.09% |
| 2021 | 5.37 | 26.35% |
| 2020 | 4.25 | 49.05% |
| 2019 | 2.85 | 18.44% |
| 2018 | 2.41 | -13.72% |
| 2017 | 2.79 | 30.12% |
| 2016 | 2.14 | -22.12% |
| 2015 | 2.75 | 18.64% |
| 2014 | 2.32 | 7.25% |
| 2013 | 2.16 | 35.29% |
| 2012 | 1.60 | 35.27% |
| 2011 | 1.18 | -33.99% |
| 2010 | 1.79 | -2.93% |
| 2009 | 1.85 | 39.83% |
| 2008 | 1.32 | -63.77% |
| 2007 | 3.64 | 33.22% |
| 2006 | 2.73 | -2.81% |
| 2005 | 2.81 | -28.71% |
| 2004 | 3.95 | 54.05% |
| 2003 | 2.56 | -18.34% |
| 2002 | 3.14 | -3.41% |
| 2001 | 3.25 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Repligen
RGEN | 10.8 | 396.73% | 🇺🇸 USA |
 SCYNEXIS SCYX | 10.5 | 382.78% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | 4.24 | 94.73% | 🇺🇸 USA |